Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound

Market Focus

Jun 16

On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by index inclusion.

On the news front, approximately 453 million shares held by cornerstone investors and employees are set to be unlocked on June 29 upon lock-up expiry, representing 81.25% of total shares outstanding. Although the company was formally included in the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Index effective June 15 — which briefly lifted sentiment — market concerns over imminent concentrated selling pressure have quickly reasserted dominance. Fundamentally, the company reported a 34.48% year-over-year revenue decline with a net loss attributable to shareholders of USD 352 million, offering limited valuation support.

Within the Life Sciences Tools and Services sector, WUXI BIO fell 1.94%, XTALPI fell 2.59%, WUXI XDC fell 2.4%, and GENSCRIPT BIO fell 2.46%, reflecting broad sector weakness that further weighed on sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1199143421"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199143421\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199143421?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 10:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199143421","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound","media":"Market Focus","content":"<p><p>On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by index inclusion.</p><p>On the news front, approximately 453 million shares held by cornerstone investors and employees are set to be unlocked on June 29 upon lock-up expiry, representing 81.25% of total shares outstanding. Although the company was formally included in the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Index effective June 15 — which briefly lifted sentiment — market concerns over imminent concentrated selling pressure have quickly reasserted dominance. Fundamentally, the company reported a 34.48% year-over-year revenue decline with a net loss attributable to shareholders of USD 352 million, offering limited valuation support.</p><p>Within the Life Sciences Tools and Services sector, WUXI BIO fell 1.94%, XTALPI fell 2.59%, WUXI XDC fell 2.4%, and GENSCRIPT BIO fell 2.46%, reflecting broad sector weakness that further weighed on sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-16 10:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by index inclusion.</p><p>On the news front, approximately 453 million shares held by cornerstone investors and employees are set to be unlocked on June 29 upon lock-up expiry, representing 81.25% of total shares outstanding. Although the company was formally included in the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Index effective June 15 — which briefly lifted sentiment — market concerns over imminent concentrated selling pressure have quickly reasserted dominance. Fundamentally, the company reported a 34.48% year-over-year revenue decline with a net loss attributable to shareholders of USD 352 million, offering limited valuation support.</p><p>Within the Life Sciences Tools and Services sector, WUXI BIO fell 1.94%, XTALPI fell 2.59%, WUXI XDC fell 2.4%, and GENSCRIPT BIO fell 2.46%, reflecting broad sector weakness that further weighed on sentiment.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1199143421","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199143421","pubTimestamp":1781575721,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易跌5.1%大规模禁售到期倒计时短暂纳入指数反弹后重拾压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by index inclusion.On the news front, approximately 453 million shares held by cornerstone investors and employees are set to be unlocked on June 29 upon lock-up expiry, representing 81.25% of total shares outstanding. Although the company was formally included in the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Index effective June 15 — which briefly lifted sentiment — market concerns over imminent concentrated selling pressure have quickly reasserted dominance. Fundamentally, the company reported a 34.48% year-over-year revenue decline with a net loss attributable to shareholders of USD 352 million, offering limited valuation support.Within the Life Sciences Tools and Services sector, WUXI BIO fell 1.94%, XTALPI fell 2.59%, WUXI XDC fell 2.4%, and GENSCRIPT BIO fell 2.46%, reflecting broad sector weakness that further weighed on sentiment.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}